Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Performance of [18F]-AV-45 in Alzheimer's Disease
NCT00855868Phase 2Completed
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Mar 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florbetapir (18F) in Alzheimer's disease (AD), sponsored by Avid Radiopharmaceuticals. Started Mar 2009; status: completed.
02
Drugs
florbetapir (18F)
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00855868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855868.